Fonar Corporation FONR Consolidates Near 19 as Key Levels Loom Federal Reserve Rate Cut Hopes Fade as Jobs Data Signals Stubborn Cost Pressures IOVA Q1 2026 Earnings EPS Misses Estimates Shares Decline 465 Praxis Precision Medicines Advances Pipeline with FDA NDA Acceptances and Strong Clinical Data